Brief: Ironwood Pharmaceuticals Q2 Revenue USD 94.396 Million Vs. IBES Estimate USD 107 Million
08/08/2024 12:00
Aug 08 (Reuters) - Ironwood Pharmaceuticals Q2 EPS USD -0.01. * Q2 adjusted net income USD 1.508 million vs. IBES estimate USD 23.5 million * Q2 adjusted EBITDA USD 27.909 million * Q2 basic EPS USD -0.01 * Q2 net income USD -860 thousand
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation